Patricia Ott
MD
Associate Professor
👥Biography 个人简介
Patricia Ott at Dana-Farber has led pivotal early phase trials of personalized neoantigen vaccines in cancer. Her landmark 2017 Nature paper reporting a small trial of individualized mutanome vaccines in melanoma — showing feasibility, immunogenicity, and early signals of clinical activity — helped launch the personalized cancer vaccine field. She has continued to develop mRNA-based neoantigen vaccine approaches in combination with pembrolizumab.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Patricia Ott 的研究动态
Follow Patricia Ott's research updates
留下邮箱，当我们发布与 Patricia Ott（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment